These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 30528196)
1. Elucidating the Variability of Magnesium Stearate and the Correlations With Its Spectroscopic Features. Wang T; Potts AR; Hoag SW J Pharm Sci; 2019 Apr; 108(4):1569-1580. PubMed ID: 30528196 [TBL] [Abstract][Full Text] [Related]
2. Understanding the impact of magnesium stearate variability on tableting performance using a multivariate modeling approach. Wang T; Ibrahim A; Hoag SW Pharm Dev Technol; 2020 Jan; 25(1):76-88. PubMed ID: 31556338 [TBL] [Abstract][Full Text] [Related]
3. Influence of moisture variation on the performance of Raman spectroscopy in quantitative pharmaceutical analyses. Hossain MN; Igne B; Anderson CA; Drennen JK J Pharm Biomed Anal; 2019 Feb; 164():528-535. PubMed ID: 30458386 [TBL] [Abstract][Full Text] [Related]
5. The impact of solid-state form, water content and surface area of magnesium stearate on lubrication efficiency, tabletability, and dissolution. Calahan JL; Paul S; Yanez EG; DeNeve D; Sun CC; Munson EJ Pharm Dev Technol; 2021 Feb; 26(2):150-156. PubMed ID: 33267700 [TBL] [Abstract][Full Text] [Related]
6. Impact of Magnesium Stearate Presence and Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N AAPS J; 2020 May; 22(4):75. PubMed ID: 32440810 [TBL] [Abstract][Full Text] [Related]
7. Influence of hydration state and homologue composition of magnesium stearate on the physical chemical properties of liquid paraffin lipogels. Sheikh KA; Kang YB; Rouse JJ; Eccleston GM Int J Pharm; 2011 Jun; 411(1-2):121-7. PubMed ID: 21457766 [TBL] [Abstract][Full Text] [Related]
8. Impact of solid-state properties on lubrication efficacy of magnesium stearate. Rao KP; Chawla G; Kaushal AM; Bansal AK Pharm Dev Technol; 2005; 10(3):423-37. PubMed ID: 16176023 [TBL] [Abstract][Full Text] [Related]
9. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations. Jetzer MW; Schneider M; Morrical BD; Imanidis G J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741 [TBL] [Abstract][Full Text] [Related]
10. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance. Lau M; Young PM; Traini D Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460 [TBL] [Abstract][Full Text] [Related]
11. Measurement of the surface energy of lubricated pharmaceutical powders by inverse gas chromatography. Swaminathan V; Cobb J; Saracovan I Int J Pharm; 2006 Apr; 312(1-2):158-65. PubMed ID: 16469458 [TBL] [Abstract][Full Text] [Related]
12. Effect of Magnesium Stearate Mono- and Dihydrate Dispersibilities on Physical Properties of Tablets. Yamamoto K; Tamura T; Yoshihashi Y; Terada K; Yonemochi E Chem Pharm Bull (Tokyo); 2017; 65(11):1028-1034. PubMed ID: 29093289 [TBL] [Abstract][Full Text] [Related]
13. Application of multivariate methods to evaluate the functionality of bovine- and vegetable-derived magnesium stearate. Haware RV; Shivagari R; Johnson PR; Staton S; Stagner WC; Gupta MR J Pharm Sci; 2014 May; 103(5):1466-77. PubMed ID: 24596131 [TBL] [Abstract][Full Text] [Related]
14. Investigation of the extent of surface coating via mechanofusion with varying additive levels and the influences on bulk powder flow properties. Zhou QT; Qu L; Gengenbach T; Denman JA; Larson I; Stewart PJ; Morton DA Int J Pharm; 2011 Jul; 413(1-2):36-43. PubMed ID: 21527321 [TBL] [Abstract][Full Text] [Related]
15. A quality-by-design study for an immediate-release tablet platform: examining the relative impact of active pharmaceutical ingredient properties, processing methods, and excipient variability on drug product quality attributes. Kushner J; Langdon BA; Hicks I; Song D; Li F; Kathiria L; Kane A; Ranade G; Agarwal K J Pharm Sci; 2014 Feb; 103(2):527-38. PubMed ID: 24375069 [TBL] [Abstract][Full Text] [Related]
16. In-line quantification of micronized drug and excipients in tablets by near infrared (NIR) spectroscopy: Real time monitoring of tabletting process. Karande AD; Heng PW; Liew CV Int J Pharm; 2010 Aug; 396(1-2):63-74. PubMed ID: 20558264 [TBL] [Abstract][Full Text] [Related]
17. Formulating weakly basic HCl salts: relative ability of common excipients to induce disproportionation and the unique deleterious effects of magnesium stearate. John CT; Xu W; Lupton LK; Harmon PA Pharm Res; 2013 Jun; 30(6):1628-41. PubMed ID: 23512680 [TBL] [Abstract][Full Text] [Related]
18. Comparison of traditional and novel tableting excipients: physical and compaction properties. Hentzschel CM; Sakmann A; Leopold CS Pharm Dev Technol; 2012; 17(6):649-53. PubMed ID: 21740091 [TBL] [Abstract][Full Text] [Related]
19. Advanced qualification of pharmaceutical excipient suppliers by multiple analytics and multivariate analysis combined. Hertrampf A; Müller H; Menezes JC; Herdling T Int J Pharm; 2015 Nov; 495(1):447-458. PubMed ID: 26342249 [TBL] [Abstract][Full Text] [Related]
20. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers. James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]